Chemotherapy free treatment of indolent lymphoma

Hematol Oncol. 2017 Jun:35 Suppl 1:20-24. doi: 10.1002/hon.2395.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use*
  • Disease-Free Survival
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphoma / classification
  • Lymphoma / drug therapy*
  • Lymphoma / mortality
  • Male
  • Survival Rate

Substances

  • Antineoplastic Agents, Immunological
  • Enzyme Inhibitors
  • Immunologic Factors